About this trial
This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide.
In addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.
Eligibility criteria
Qualifiers
Stratum A: participant suspected or confirmed diagnosis of adrenocortical tumor (ACT)
Stratum R: relative of participant with ACT and TP53 mutation who has diagnosis of malignancy
Stratum P: biological parent of participant with ACT
Age ≤ 21 years old at diagnosis
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed